Literature DB >> 2859295

Positron emission tomography in schizophrenic patients with and without neuroleptic medication.

L E DeLisi, H H Holcomb, R M Cohen, D Pickar, W Carpenter, J M Morihisa, A C King, R Kessler, M S Buchsbaum.   

Abstract

Positron emission tomography using [18F]2-fluoro-2-deoxy-D-glucose was performed in nine chronic schizophrenic patients both when medication-free and when medicated with neuroleptics. Total brain cortex, temporal cortex, and basal ganglia glucose use was significantly increased with medication; however, there was no change in anterior/posterior metabolic gradients.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2859295     DOI： 10.1038/jcbfm.1985.26

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN： 0271-678X            Impact factor:   6.200


  12 in total

Review 1.  Functional brain mapping of psychopathology.

Authors:  G D Honey; P C Fletcher; E T Bullmore
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 2.  Structural and functional brain imaging in schizophrenia.

Authors:  J M Cleghorn; R B Zipursky; S J List
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

3.  Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.

Authors:  M Soyka; W Koch; H J Möller; T Rüther; K Tatsch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-18       Impact factor: 5.270

4.  Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride.

Authors:  C J Bench; A A Lammertsma; R J Dolan; P M Grasby; S J Warrington; K Gunn; M Cuddigan; D J Turton; S Osman; R S Frackowiak
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography.

Authors:  A Wolkin; B Angrist; A Wolf; J Brodie; B Wolkin; J Jaeger; R Cancro; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  F-18 fluorodeoxyglucose positron emission tomography study of impaired emotion processing in first episode schizophrenia.

Authors:  Mona Choudhary; Arvind Kumar; Madhavi Tripathi; Triptish Bhatia; Venkataram Shivakumar; Ram Pratap Beniwal; Ruben C Gur; Raquel E Gur; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Schizophr Res       Date:  2015-02-02       Impact factor: 4.939

7.  Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity?

Authors:  R J Dolan; C J Bench; P F Liddle; K J Friston; C D Frith; P M Grasby; R S Frackowiak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-12       Impact factor: 10.154

8.  Left globus pallidus abnormality in never-medicated patients with schizophrenia.

Authors:  T S Early; E M Reiman; M E Raichle; E L Spitznagel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

9.  Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography.

Authors:  G Wik; F A Wiesel; I Sjögren; G Blomqvist; T Greitz; S Stone-Elander
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

10.  Fiber pathway pathology, synapse loss and decline of cortical function in schizophrenia.

Authors:  Max R Bennett; Les Farnell; William G Gibson
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.